These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24928084)

  • 1. The wide gulf between stage III and stage IV colon cancer.
    Ting DT; Ryan DP
    Lancet Oncol; 2014 Jul; 15(8):785-6. PubMed ID: 24928084
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
    Taieb J; Tabernero J; Mini E; Subtil F; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Petersen LN; Blons H; Collette L; Van Cutsem E; Rougier P; Salazar R; Bedenne L; Emile JF; Laurent-Puig P; Lepage C;
    Lancet Oncol; 2014 Jul; 15(8):862-73. PubMed ID: 24928083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenge of primary tumor management in patients with stage IV colorectal cancer.
    Chang GJ
    J Clin Oncol; 2012 Sep; 30(26):3165-6. PubMed ID: 22869881
    [No Abstract]   [Full Text] [Related]  

  • 4. Current stages of adjuvant treatment of colon cancer.
    Köhne CH
    Ann Oncol; 2012 Sep; 23 Suppl 10():x71-6. PubMed ID: 22987996
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
    Ojima E; Nakano T; Kanamoto A; Sasaki S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy and safety of antivascular drugs after anti-EFGR: aflibercept after cetuximab, a clinical case].
    Aroldi F; Zaniboni A
    Recenti Prog Med; 2015 Dec; 106(12):653e-6e. PubMed ID: 26780078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?
    Trivedi ND; Marshall JL
    Oncology (Williston Park); 2017 Dec; 31(12):863-5, 871, 884. PubMed ID: 29297170
    [No Abstract]   [Full Text] [Related]  

  • 9. N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.
    Alberts SR; Sinicrope FA; Grothey A
    Clin Colorectal Cancer; 2005 Sep; 5(3):211-3. PubMed ID: 16197625
    [No Abstract]   [Full Text] [Related]  

  • 10. NCCN guideline updates: colon and rectal cancers, version 1.2004.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Jul; 2(4):284-5. PubMed ID: 19795595
    [No Abstract]   [Full Text] [Related]  

  • 11. Leucovorin-induced hypersensitivity reaction.
    Damaske A; Ma N; Williams R
    J Oncol Pharm Pract; 2012 Mar; 18(1):136-9. PubMed ID: 21248170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.
    Venook AP; Blanke CD; Niedzwiecki D; Lenz HJ; Taylor JR; Hollis DR; Sutherland S; Goldberg RM
    Clin Colorectal Cancer; 2005 Nov; 5(4):292-4. PubMed ID: 16356309
    [No Abstract]   [Full Text] [Related]  

  • 13. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
    Grothey A; Sargent DJ
    J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of multiple skin metastases from cancer of the descending colon responding to FOLFIRI/cetuximab therapy].
    Kadota T; Osuga T; Ogawa H; Kitami M; Ishimura M; Shigaki Y; Nakajima E; Nakata S; Kadota C; Hirano S; Ikura Y; Iwai Y; Yoshikawa T; Ueno N; Tamura T
    Nihon Shokakibyo Gakkai Zasshi; 2014 Jan; 111(1):115-23. PubMed ID: 24390266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver resection after FOLFOX with bevacizumab.
    Mickle M; Mulcahy MF
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
    [No Abstract]   [Full Text] [Related]  

  • 16. PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial.
    Aparicio T; Francois E; Cristol-Dalstein L; Carola E; Maillard E; Paillaud E; Retornaz F; Faroux R; André T; Bedenne L; Seitz JF
    Dig Liver Dis; 2016 Feb; 48(2):206-7. PubMed ID: 26748426
    [No Abstract]   [Full Text] [Related]  

  • 17. Selecting regimens in advanced colon cancer.
    Diasio RB
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-19-24. PubMed ID: 23570094
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
    Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
    [No Abstract]   [Full Text] [Related]  

  • 19. Bevacizumab in the treatment of colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):8-9. PubMed ID: 17491585
    [No Abstract]   [Full Text] [Related]  

  • 20. Colon carcinoma in a child treated with oxaliplatin and antiangiogenic treatment regimens.
    Krstovski N; Dokmanovic L; Lazic J; Rodic P; Paripovic L; Janic D
    Pediatr Hematol Oncol; 2012 Sep; 29(6):549-50. PubMed ID: 22839297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.